FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets

29,014 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 2400 - 2600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1567Bacteria [Causing Meningitis] (Tests by Culture and Identification Method)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1574Invasive Group B Streptococcus (Disorders) (ICD10CM))active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1577Group A Streptococcus (Tests for Group A Strep by Culture and Identification Method)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1578Group B Streptococcus (Tests for Group B Strep by Culture and Identification Method)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1580Animal Bite [Dog] (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1581Animal Bite [Mammal, Excluding Dogs] (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1582Animal Bite [Excluding Mammals] (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1584Animal Bite [Unspecified Animal] (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1585Animal Bite [Dog] (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1586Animal Bite [Mammal, Excluding Dogs] (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1587Animal Bite [Excluding Mammals] (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1588Cadmium Exposure and Toxicity (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1604Vaccine Adverse Event (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1605Vaccine Adverse Event (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1606Vaccinia disease or adverse event  (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.161Vibriosis (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1612Blepharitis [Unspecified Cause] (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1613Keratitis [Unspecified Cause] (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1614Keratitis [Unspecified Cause] (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1620Anaphylaxis [Unspecified Cause] (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1626Thrombocytopenic Purpura [Unspecified Cause] (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1640Typhus Fever (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1641Typhus Fever (Tests for Rickettsia Typhus Group IgG Antibody)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1642Typhus Fever (Tests for Rickettsia Typhus Group IgM Antibody)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1643Typhus Fever (Tests for Rickettsia Typhus Fever Group IgG Antibody [Quantitative] by Immunofluorescence)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1651Chagas Disease (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1654Chagas Disease (Tests for Trypanosoma cruzi Antibody)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1661Cervical lymphadenopathy [Unspecified Cause] (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1662Conjunctival injection (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1663Drying of lips (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1667Edema of hands or feet (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1676Tests for Acinetobacter baumannii Nucleic Acidactive2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1677Tests for Pseudomonas aeruginosa by Culture and Identification Methodactive2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1678Tests for Pseudomonas aeruginosa Nucleic Acidactive2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1679Pseudomonas aeruginosa (Organism or Substance in Lab Results)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1687NU_Gunshot Wound (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1688NU_Gunshot Wound (Disorders) (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.169Gonorrhea [Neisseria gonorrhoeae] (Organism or Substance in Lab Results)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.170Chlamydia trachomatis Infection (Organism or Substance in Lab Results)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1700Encephalitis [Viral] (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1702Encephalitis [Parasitic] (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1712Bacteria [Causing Encephalitis] (Organism or Substance in Lab Results)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1714Parasites [Causing Encephalitis] (Organism or Substance in Lab Results)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1715Viruses [Causing Encephalitis] (Organism or Substance in Lab Results)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1716Drowning and Submersion (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1717Drowning and Submersion (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1718Motor Vehicle Injury (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1719Motor Vehicle Injury (Disorders) (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1720Enterovirus Infection [Non polio] (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1721Enterovirus Infection [Non polio] (Disorders) (ICD10CM)active2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1722Enterovirus Infection [Non polio] (Organism or Substance in Lab Results)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1723Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus by Culture and Identification Method)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1725Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus Nucleic Acid)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1726Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus in Cerebrospinal Fluid Nucleic Acid)active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1735Clostridium perfringens Infection (Tests for C perfringens by Culture and Identification Method)active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1739Head Injury (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1740Head Injury (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1742Brain Injury [Traumatic] (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1745Rotavirus Disease (Organism or Substance in Lab Results)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1746Rotavirus Disease (Tests for Rotavirus Nucleic Acid)active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1748Chemical Pneumonitis (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1749Chemical Pneumonitis (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1753Staphylococcal Enterotoxin B Poisoning (Tests for Staph aureus Enterotoxin B Nucleic Acid)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1755Vomitus (Specimen Type) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1758Asbestosis (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.176West Nile Virus Infection (Disorders) (ICD10CM)active2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1763Byssinosis (Disorders) (ICD10CM)active2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1769Farmers Lung (Tests for Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1772Farmers Lung (Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody in Lab Results)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1773CLABSI (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1775Ophthalmia neonatorum (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1778Genital herpes (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1779Genital herpes (Disorders) (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1781Herpes (Tests for Herpes simplex virus Nucleic Acid)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1785Elevated liver enzyme (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1786Elevated liver enzyme (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1788Typhus Fever (Tests for Rickettsia Typhus Fever Group IgM Antibody [Quantitative] by Immunofluorescence)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1789Granuloma Inguinale (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1791Ulcer [Genital, Perineal, or Perianal Area] (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1792Ulcer [Genital, Perineal, or Perianal Area] (ICD10CM)active2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1797Bronchial Wash (Specimen Type) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1800Nontuberculous Mycobacteria Infection, Pulmonary (Organism or Substance in Lab Results)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1803Bacteria (Tests in Sputum Specimen by Culture and Identification Method)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1819Louseborne relapsing fever (Tests for Borrelia species)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1820Louseborne relapsing fever (Tests for Borrelia species in Blood)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1823Borrelia species (Organism or Substance in Lab Results)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1824Spirochetes (Organism or Substance in Lab Results)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1829Polyarthritis [Unspecified Cause] (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1835Rheumatoid nodules (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1842Ventilator associated event (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1844Leishmaniasis (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1846Leishmaniasis (Tests for Leishmania species Nucleic Acid)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1847Leishmaniasis (Tests for Leishmania species Antibody)active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1848Leishmania species (Tests by Microscopic Observation in Tissue)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.185Brucellosis (Disorders) (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1864Taeniasis (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1866Taeniasis (Organism or Substance in Lab Results)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.187Dengue Virus Infection (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1875Cysticercosis (Tests for Taenia solium Antibody)active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1878Surgical Site Infection (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1880Tests for Enterobacter spp., E. coli, or Klebsiella spp. Nucleic Acidactive2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1881NU_Tests for Enterobacteriaceae species Nucleic Acidactive2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1882Carbapenemase production (Organism or Substance in Lab Results)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1892Toxoplasmosis (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1893Toxoplasmosis (Disorders) (ICD10CM)active2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1895Toxoplasmosis (Organism or Substance in Lab Results)active2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1897Toxoplasmosis (Tests by Microscopic Observation)active2023-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1898Toxoplasmosis (Tests for Toxoplasma gondii Nucleic Acid)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1901Toxoplasmosis (Tests for Toxoplasma gondii Antibody)active2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1902Orthopox (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1908Organisms (Tests by Electron Microscopic Observation)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1919Fungi [Causing Meningitis] (Tests by Culture and Identification Method)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1923Coronary artery aneurysm (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1924Coronary artery dilatation (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1925Ectatic coronary artery (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1926Left ventricular ejection fraction [Decreased Level] (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1927Coronary artery aneurysm (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1928Shock (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1929Shock (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1930Troponin [Elevated Level] (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1931Oral mucosa Inflammation (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1932Oral mucosa Inflammation (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1933C reactive protein (Tests by Any Method)active2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1934Lymphocytes [Concentration] (Tests by Any Method)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1935Strongyloidiasis (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1936Strongyloidiasis (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1937Strongyloidiasis (Tests for Strongyloides Nucleic Acid)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1938Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1939Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody in Blood)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1940Organisms (Tests by Microscopic Observation in Stool)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1941Strongyloidiasis (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1942Strongyloidiasis [Strongyloides stercoralis] (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1943Jamestown Canyon Virus Diseases (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1944Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Nucleic Acid)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1945Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus IgM Antibody)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1946Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Antibody)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1947Jamestown Canyon Virus Diseases (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1948Keystone Virus Diseases (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1949La Crosse Virus Diseases (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1950Snowshoe hare Virus Diseases (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1951Trivittatus Virus Diseases (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1952La Crosse Virus Diseases (Tests for La Crosse Virus Nucleic Acid)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1953Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Nucleic Acid)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1954La Crosse Virus Diseases (Tests for La Crosse Virus IgM Antibody)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1955Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus IgM Antibody)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1956La Crosse Virus Diseases (Tests for La Crosse Virus Antibody)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1957Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Antibody)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1958Trivittatus Virus Diseases (Tests for Trivittatus Virus Antibody)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1959Keystone Virus Diseases (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1960La Crosse Virus Diseases (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1961Snowshoe hare Virus Diseases (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1962Trivittatus Virus Diseases (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1963Hepatitis C Virus Infection, Perinatal (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1964Encephalomyelitis (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1965Encephalomyelitis (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1966Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1967Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1968Hepatitis D Virus Infection (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1969Hepatitis D Virus Infection (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1970NU_Hepatitis D Virus Infection (Tests for hepatitis D virus total or IgG Antibody)active2024-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1971Hepatitis D Virus Infection (Tests for hepatitis D virus IgM Antibody)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1972Hepatitis D Virus Infection (Tests for hepatitis D virus Nucleic Acid)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1973Hepatitis D Virus Infection (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1974Baylisascariasis (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1975Baylisascariasis (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1976Baylisascariasis (Tests for Baylisascaris species Antibody)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1978Larva Migrans (Neural, Ocular, or Visceral) (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1979Larva Migrans (Neural, Ocular, or Visceral) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1980California Serogroup Virus Disease [Unspecified] (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1981California Serogroup Virus Disease [Unspecified] (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1982California Serogroup Virus Disease [Unspecified] (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1983California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Nucleic Acid)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1984California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus IgM Antibody)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1985California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Antibody)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1986Pregnant (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1987Flank Pain (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1988Bone Pain (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1989Abscess (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1990Abscess (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1991Focal Brain Lesions (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1992Pathologic Fractures [Unspecified Cause] (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1993Pathologic Fractures [Unspecified Cause] (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1994Granulomas (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1995Granulomas (ICD10CM)active2024-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1996Skin Lesions (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1997Skin Lesions (ICD10CM)active2024-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1998Angiostrongyliasis (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1999Lymphocytic Choriomeningitis (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2000Lymphocytic Choriomeningitis (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2001Lymphocytic Choriomeningitis (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2002Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2003Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid in CSF or Blood)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2004Lymphocytic Choriomeningitis (Tests for LCMV Antibody)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2005Lymphocytic Choriomeningitis (Tests for LCMV Antibody in CSF or Serum)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2006Angiostrongyliasis (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2007Eosinophilic meningitis (SNOMED)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2009Angiostrongyliasis (Tests for Angiostrongylus Nucleic Acid)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2010Eosinophils [Concentration] (Tests in CSF by Any Method)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2011Eosinophils [Percentage] (Tests in CSF by Any Method)active2023-01ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2012Mpox (Tests for mpox virus by Genomic Sequencing)active2023-01ushl7loinc